INFANT NUTRITION & PRIVATE LABEL SOLUTIONS INTERNATIONAL SUPPLY · TÜRKİYE / EUROPE

OUR PRODUCTS / SPECIALISED

Specialised
Formula Concepts.

Dedicated product briefs for specific nutritional needs, subject to regulatory classification, clinical assessment and professional supervision.

TECHNICAL PORTFOLIO

Purpose-defined formulations.

Specialised products are not automatically interchangeable with standard infant formula.

01 / AR

Anti-Reflux Formula

Thickened or otherwise adapted formula concepts assessed for the intended regulatory category and clinical use.

Category and composition require approval
02 / LF

Lactose-Free Formula

Lactose-free concepts reviewed against permitted carbohydrate and nutritional composition requirements.

Indication-specific professional guidance
03 / PRE

Preterm Formula

Specialised concepts for premature infants requiring strict clinical and regulatory oversight.

Clinical use only · subject to approval
Professional use and approvals

Specialised formulas may be subject to additional legal requirements and must never be chosen solely from website descriptions. Professional assessment and approved labelling are essential.

SPECIALISED / REGULATORY PATH

Specialised formula needs specialised review.

Anti-reflux, lactose-free and preterm products may be classified differently by market and should not be positioned as general-purpose products without review.

01 / ANTI-REFLUX / AR

Anti-reflux / AR

Assess the intended thickening system, preparation method and clinical-use category; supporting evidence and product information are reviewed before release.

02 / LACTOSE-FREE / LF

Lactose-free / LF

Confirm whether the formulation is intended for a specific dietary need, and validate its lactose declaration and applicable regulatory category.

03 / PRETERM / PRE

Preterm / PRE

Any formula intended for premature infants requires appropriate specialist oversight and regulatory confirmation before it is offered or communicated.

04 / EVIDENCE AND DOCUMENTATION

Evidence and documentation

Review intended-use statements, warnings, clinical considerations, manufacturing evidence and the receiving market’s registration pathway.